Production (Stage)
CorMedix Inc.
CRMD
$12.36
$0.100.82%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 95.08% | -- | -- | -- | -- |
| Gross Profit | 4,679.71% | -- | -- | -- | -- |
| SG&A Expenses | -5.86% | 14.89% | 70.82% | 113.22% | 97.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.48% | 16.63% | 40.85% | 36.45% | 51.62% |
| Operating Income | 220.48% | 182.56% | 68.59% | -29.62% | -51.62% |
| Income Before Tax | 230.16% | 191.26% | 71.50% | -25.53% | -50.10% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 242.71% | 191.26% | 71.50% | -25.53% | -36.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 242.71% | 191.26% | 71.50% | -25.53% | -36.90% |
| EBIT | 220.48% | 182.56% | 68.59% | -29.62% | -51.62% |
| EBITDA | 221.61% | 183.51% | 69.28% | -29.16% | -51.65% |
| EPS Basic | 225.76% | 185.14% | 72.61% | 1.17% | -4.96% |
| Normalized Basic EPS | 214.73% | 185.13% | 72.61% | 1.16% | -15.09% |
| EPS Diluted | 219.24% | 185.14% | 72.61% | 1.17% | -4.96% |
| Normalized Diluted EPS | 208.53% | 185.13% | 72.61% | 1.16% | -15.09% |
| Average Basic Shares Outstanding | 13.46% | 7.17% | 4.02% | 27.01% | 30.42% |
| Average Diluted Shares Outstanding | 19.95% | 7.17% | 4.02% | 27.01% | 30.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |